financetom
Business
financetom
/
Business
/
ASML shares rise on CFO Dassen's comments on orders
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ASML shares rise on CFO Dassen's comments on orders
Jun 5, 2024 6:59 AM

AMSTERDAM (Reuters) - ASML shares rose on Wednesday after a Jefferies analyst report cited comments from CFO Roger Dassen which suggested he was positive about the possibility of orders coming through from top customer TSMC in the coming quarters.

An ASML spokesperson confirmed the CFO had spoken at a Jefferies-hosted call with investors.

ASML's shares rose 6.3% to 927.10 euros ($1,008.78) by 1314 GMT.

ASML, the world's biggest semiconductor equipment maker, makes lithography tools, which use beams of light to help create the minute circuitry of computer chips, while TSMC is the world's biggest maker of advanced chips.

The Jefferies report said Dassen "sounded optimistic" that commercial talks with TSMC were nearing conclusion, with "significant" 2 nm-related orders coming through, starting in Q2 or Q3.

ASML has previously said it targets 2025 sales in the 30-40 billion euro range, helped by booming demand for cutting-edge logic chips used in smartphones and for AI.

The Jefferies report said the company sees demand continuing to be strong into 2026, helped by government-subsidised factories being built around the world.

The report said TSMC expects to receive one of ASML's new High NA extreme ultraviolet (EUV) machines, which cost more than 350 million euros each, sometime this year.

Intel was the first to purchase one of the machines, with the other installed in an ASML-Imec laboratory that opened this week.

ASML has orders for more than a dozen of the High NA tools from all the customers who use its current EUV line, which includes: Intel, TSMC, Samsung, SK Hynix and Micron.

The Jefferies report also said ASML does not believe it will face competition in EUV technology from either Chinese lithography company SMEE or Huawei "in the foreseeable future due to the complexity of the technology itself as well as the ecosystem."

($1 = 0.9190 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--KLA (KLAC) Says to Raise Quarterly Dividend 17% to $1.70 per Share, Starting With Dividend to be Declared in November
--KLA (KLAC) Says to Raise Quarterly Dividend 17% to $1.70 per Share, Starting With Dividend to be Declared in November
Sep 4, 2024
04:51 PM EDT, 09/03/2024 (MT Newswires) -- KLA (KLAC) said Tuesday it will raise its quarterly dividend by 17%, from $1.45 to $1.70 per share, starting with the dividend to be announced in November 2024. ...
Volkswagen goes head-to-head with workers over proposed cuts
Volkswagen goes head-to-head with workers over proposed cuts
Sep 4, 2024
WOLFSBURG, Germany (Reuters) -Volkswagen management is facing workers at a crunch meeting at its headquarters on Wednesday as the automaker seeks to push through deep cost cuts - including factory closures in Germany - in an effort to revive profits at its namesake brand. Chief Financial Officer Arno Antlitz and VW brand chief Thomas Schaefer will give speeches detailing the...
Graphic Packaging Sees 2024 Adjusted EPS Below Midpoint of Guidance
Graphic Packaging Sees 2024 Adjusted EPS Below Midpoint of Guidance
Sep 4, 2024
04:58 PM EDT, 09/03/2024 (MT Newswires) -- Graphic Packaging ( GPK ) expects full-year adjusted earnings per share to be below the midpoint of July 30 guidance of $2.65 to $2.85. Analysts polled by Capital IQ expect $2.72. Output disruptions, lost production and restart costs contributed to the revised outlook, the company said Tuesday. Price: 29.00, Change: -0.32, Percent Change:...
BD Closes Acquisition of Edwards Lifesciences' Critical Care Business
BD Closes Acquisition of Edwards Lifesciences' Critical Care Business
Sep 4, 2024
04:54 PM EDT, 09/03/2024 (MT Newswires) -- BD (BDX) said Tuesday it has completed the acquisition of Edwards Lifesciences' ( EW ) critical care business and will be renamed BD Advanced Patient Monitoring. The deal is expected to have an immaterial impact to BD's previously released fiscal 2024 outlook. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved